{
  "trial_id": "NCT02564848",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Female",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Age > 65",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Staging: T1-2N0 ER+ invasive breast cancer",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Plan to undergo lumpectomy within 3 months of study registration",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Ductal or lobular carcinoma in situ",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Inflammatory breast cancer",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Neoadjuvant chemotherapy for current primary breast cancer",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of 3 pregnancies and live births, and is currently using multivitamins daily.",
  "_meta": {
    "topic_id": "25",
    "trial_id": "NCT02564848",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}